Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 2

1(25.0%)

Phase 3

1(25.0%)

4Total

N/A(2)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03688165Completed

The Effects of Gait Rehabilitation After Stroke by Treadmill-based Robotics Versus Traditional Gait Training

Role: collaborator

NCT05157165Unknown

Convalescent Plasma in Hospitalized COVID-19 Patients

Role: lead

NCT05851755Enrolling By Invitation

Italian Lung Cancer Observational Study

Role: collaborator

NCT03197142Unknown

Cardiac Arrest Registry of the Lombardia Region (Lombardia CARe)

Role: collaborator

NCT05057598Not ApplicableRecruiting

DianaWeb: Before and After Study Online Based Participatory Research on Breast Cancer Women

Role: collaborator

NCT05019989Not ApplicableCompleted

Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study

Role: collaborator

NCT04569188Phase 2Completed

Convalescent Plasma in COVID-19 Elderly Patients

Role: lead

NCT03351569Phase 3Unknown

Intravenous Immunoglobulin for Unverricht-Lundborg Disease.

Role: lead

All 8 trials loaded